Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
3.6M
-
Shares change
-
-635
-
Total reported value, excl. options
-
$43.3M
-
Value change
-
+$3.07M
-
Put/Call ratio
-
1.29
-
Number of buys
-
32
-
Number of sells
-
-28
-
Price
-
$12.03
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q4 2022
92 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q4 2022.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.6M shares
of 41M outstanding shares and own 8.78% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (490K shares), JPMORGAN CHASE & CO (405K shares), Lindbrook Capital, LLC (383K shares), MORGAN STANLEY (316K shares), TWO SIGMA ADVISERS, LP (252K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (186K shares), JANE STREET GROUP, LLC (133K shares), BlackRock Inc. (106K shares), GROUP ONE TRADING, L.P. (102K shares), and CITIGROUP INC (65.9K shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.